596 related articles for article (PubMed ID: 18182324)
21. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Triolo TM; Bellin MD
Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
[TBL] [Abstract][Full Text] [Related]
22. Cell therapies for pancreatic beta-cell replenishment.
Okere B; Lucaccioni L; Dominici M; Iughetti L
Ital J Pediatr; 2016 Jul; 42(1):62. PubMed ID: 27400873
[TBL] [Abstract][Full Text] [Related]
23. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy of type 1 diabetes.
Li L; Yi Z; Tisch R; Wang B
Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
26. Biological and biomaterial approaches for improved islet transplantation.
Narang AS; Mahato RI
Pharmacol Rev; 2006 Jun; 58(2):194-243. PubMed ID: 16714486
[TBL] [Abstract][Full Text] [Related]
27. Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny.
Lees JG; Tuch BE
Regen Med; 2006 May; 1(3):327-36. PubMed ID: 17465786
[TBL] [Abstract][Full Text] [Related]
28. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of stem cells into insulin-producing cells: current status and challenges.
Pokrywczynska M; Krzyzanowska S; Jundzill A; Adamowicz J; Drewa T
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):149-58. PubMed ID: 23283518
[TBL] [Abstract][Full Text] [Related]
30. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
31. Stem cells and regenerative medicine for the treatment of type 1 diabetes: the challenges lying ahead.
Lechner A
Pediatr Diabetes; 2004; 5 Suppl 2():88-93. PubMed ID: 15601379
[TBL] [Abstract][Full Text] [Related]
32. Current perspectives of biotechnological replacement of insulin secreting cells.
Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2000; 108(8):494-7. PubMed ID: 11149623
[No Abstract] [Full Text] [Related]
33. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes.
Roche E; Reig JA; Campos A; Paredes B; Isaac JR; Lim S; Calne RY; Soria B
Transpl Immunol; 2005 Dec; 15(2):113-29. PubMed ID: 16412956
[TBL] [Abstract][Full Text] [Related]
34. Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes.
Tahbaz M; Yoshihara E
Front Endocrinol (Lausanne); 2021; 12():716625. PubMed ID: 34447354
[TBL] [Abstract][Full Text] [Related]
35. Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.
Ye J; Liao YT; Jian YQ; Zhang XD; Wei P; Qi H; Deng CY; Li FR
Immunol Lett; 2013 Feb; 150(1-2):61-8. PubMed ID: 23333354
[TBL] [Abstract][Full Text] [Related]
36. Advances in islet encapsulation technologies.
Desai T; Shea LD
Nat Rev Drug Discov; 2017 May; 16(5):338-350. PubMed ID: 28008169
[TBL] [Abstract][Full Text] [Related]
37. The stages of type 1A diabetes: 2005.
Gianani R; Eisenbarth GS
Immunol Rev; 2005 Apr; 204():232-49. PubMed ID: 15790362
[TBL] [Abstract][Full Text] [Related]
38. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".
Kent SC; Mannering SI; Michels AW; Babon JAB
Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875
[TBL] [Abstract][Full Text] [Related]
39. [Insulin-secreting organoids: a first step towards the bioartificial pancreas].
Lebreton F; Wassmer CH; Belofatto K; Berney T; Berishvili E
Med Sci (Paris); 2020 Oct; 36(10):879-885. PubMed ID: 33026330
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of peripheral tolerance to islet antigens.
Hamilton-Williams EE; Bergot AS; Reeves PL; Steptoe RJ
J Autoimmun; 2016 Aug; 72():118-25. PubMed ID: 27255733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
